Related Experiment Videos
Antenatal corticosteroid increases serum ceruloplasmin activity in premature neonates
T Szabó1, G Oroszlán, L Lakatos
1Department of Pediatrics, University Medical School, Debrecen, Hungary.
Insights
Antenatal corticosteroids significantly boost ceruloplasmin levels in premature infants, reducing respiratory distress syndrome risks. This enzyme activity is crucial for neonatal health outcomes.
Area of Science:
- Neonatal Medicine
- Biochemistry
- Pediatrics
Background:
- Serum ceruloplasmin is a key enzyme with antioxidant and iron transport functions.
- Ceruloplasmin levels are known to be lower in premature neonates compared to full-term infants.
- The role of antenatal factors in modulating neonatal enzyme activity requires further investigation.
Purpose of the Study:
- To investigate the impact of antenatal corticosteroid treatment on serum ceruloplasmin activity in neonates.
- To determine the correlation between initial ceruloplasmin levels and the incidence of respiratory distress syndrome (RDS) in premature infants.
Main Methods:
- Serum ceruloplasmin activity was measured in full-term and premature neonates on the first day of life.
- Premature neonates were categorized based on whether they received antenatal corticosteroid treatment more than 24 hours prior to birth.
- Statistical analysis was performed to assess the correlation between ceruloplasmin activity and RDS morbidity/mortality.
Main Results:
- Premature neonates born after antenatal corticosteroid treatment exhibited ceruloplasmin activity comparable to full-term neonates.
- Premature infants born without steroid prophylaxis showed significantly lower or undetectable ceruloplasmin activity.
- A highly significant correlation was found between initial serum ceruloplasmin activity and the morbidity and mortality associated with respiratory distress syndrome.
Conclusions:
- Antenatal corticosteroid administration effectively enhances serum ceruloplasmin activity in premature neonates.
- Adequate ceruloplasmin levels in early life are strongly associated with reduced respiratory distress syndrome severity and mortality.
- Measuring early serum ceruloplasmin activity may serve as a prognostic indicator for respiratory distress syndrome in neonates.
Abstract:
Serum ceruloplasmin activity in full term and premature neonates was measured on the first day of life. Preterm newborns were born more than 24 hours after antenatal corticosteroid treatment, had enzyme activity equivalent to that of the full term babies. Little or no ceruloplasmin activity was found in those prematures who were born without steroid prophylaxis. Highly significant correlation was observed between the initial ceruloplasmin activity and the morbidity and mortality of respiratory distress syndrome.